{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:20:04Z","timestamp":1790857204944,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,11,18]],"date-time":"2010-11-18T00:00:00Z","timestamp":1290038400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00280-010-1518-3","type":"journal-article","created":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T04:35:39Z","timestamp":1289968539000},"page":"513-524","source":"Crossref","is-referenced-by-count":65,"title":["Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination"],"prefix":"10.1007","volume":"68","author":[{"given":"Lee","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori U.","family":"Coward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Noker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Brooks","family":"Harder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Muzzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bellur","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapas K.","family":"Das Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Beattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,18]]},"reference":[{"key":"1518_CR1","doi-asserted-by":"crossref","unstructured":"Gorman GS, Coward LU, Freeman L, Noker PE, Beattie CW, Jia L (2010) A novel and rapid LC\/MS\/MS assay for bioanalysis of azurin p28 in serum and its pharmacokinetics in mice. J Pharm Biomed Anal 53:991\u2013996","DOI":"10.1016\/j.jpba.2010.06.006"},{"key":"1518_CR2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2174\/138920007782798207","volume":"8","author":"L Jia","year":"2007","unstructured":"Jia L, Liu X (2007) The conduct of drug metabolism studies considered good practice (II): in vitro experiments. Curr Drug Metab 8:822\u2013829","journal-title":"Curr Drug Metab"},{"key":"1518_CR3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/sj.bjp.0706650","volume":"147","author":"L Jia","year":"2006","unstructured":"Jia L, Noker PE, Coward L, Gorman GS, Protopopova M, Tomaszewski JE (2006) Interspecies pharmacokinetics and in vitro metabolism of SQ109. Br J Pharmacol 147:476\u2013485","journal-title":"Br J Pharmacol"},{"key":"1518_CR4","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1211\/jpp.60.11.0004","volume":"60","author":"L Jia","year":"2008","unstructured":"Jia L, Noker PE, Piazza GA, Leuschner C, Hansel W, Gorman GS, Coward LU, Tomaszewski J (2008) Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugate. J Pharm Pharmacol 60:1441\u20131448","journal-title":"J Pharm Pharmacol"},{"key":"1518_CR5","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/sj.onc.1207376","volume":"23","author":"V Punj","year":"2004","unstructured":"Punj V, Bhattacharyya S, Saint-Dic D, Vasu C, Cunningham EA, Graves J, Yamada T, Constantinou AI, Christov K, White B, Li G, Majumdar D, Chakrabarty AM, Das Gupta TK (2004) Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. Oncogene 23:2367\u20132378","journal-title":"Oncogene"},{"key":"1518_CR6","first-page":"2457","volume":"14","author":"S Rauth","year":"1994","unstructured":"Rauth S, Kichina J, Green A, Bratescu L, Das Gupta TK (1994) Establishment of a human melanoma cell line lacking p53 expression and spontaneously metastasizing in nude mice. Anticancer Res 14:2457\u20132463","journal-title":"Anticancer Res"},{"key":"1518_CR7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1158\/0008-5472.CAN-08-2932","volume":"69","author":"BN Taylor","year":"2009","unstructured":"Taylor BN, Mehta RR, Yamada T, Lekmine F, Christov K, Green A, Bratescu L, Shilkaitis A, Chakrabarty AM, Beattie CW, Das Gupta TK (2009) Noncationic peptides obtained from azurin preferentially enter cancer cells. Cancer Res 69:537\u2013546","journal-title":"Cancer Res"},{"key":"1518_CR8","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1462-5822.2005.00567.x","volume":"7","author":"T Yamada","year":"2005","unstructured":"Yamada T, Fialho AM, Punj V, Bratescu L, Gupta TK, Chakrabarty AM (2005) Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity. Cell Microbiol 7:1418\u20131431","journal-title":"Cell Microbiol"},{"key":"1518_CR9","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1073\/pnas.0400899101","volume":"101","author":"T Yamada","year":"2004","unstructured":"Yamada T, Hiraoka Y, Ikehata M, Kimbara K, Avner BS, Das Gupta TK, Chakrabarty AM (2004) Apoptosis or growth arrest: modulation of tumor suppressor p53\u2019s specificity by bacterial redox protein azurin. Proc Natl Acad Sci USA 101:4770\u20134775","journal-title":"Proc Natl Acad Sci USA"},{"key":"1518_CR10","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1158\/1535-7163.MCT-09-0444","volume":"8","author":"T Yamada","year":"2009","unstructured":"Yamada T, Mehta RR, Lekmine F, Christov K, King ML, Majumdar D, Shilkaitis A, Green A, Bratescu L, Beattie CW, Das Gupta TK (2009) A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells. Mol Cancer Ther 8:2947\u20132958","journal-title":"Mol Cancer Ther"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-010-1518-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1518-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T09:42:08Z","timestamp":1559814128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-010-1518-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,18]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1518"],"URL":"https:\/\/doi.org\/10.1007\/s00280-010-1518-3","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,18]]}}}